Home' Australian Pharmacist : Australian Pharmacist June 2013 Contents 10 Australian Pharmacist June 2013 I ©Pharmaceutical Society of Australia Ltd.
'This Budget outcome should also provide
the Government with the confidence
that it can act expeditiously on PBAC
recommendations and provide Australian
patients with timely access to new
medicines,' he said.
Self education costs capped
A $2,000 cap on tax deductibility of self
education expenses will start from 1 July
2014. This is estimated to save the Budget
$514 million over four years.
The 2013 Federal Budget provided
some more details on the previously
The Government was set to release a
discussion paper on the issue in late May.
Deductible education expenses are
costs incurred in undertaking a course of
study or other education activity such as
workshops or conferences, and include
tuition fees, registration fees, student
amenity fees, text books, professional and
trade journals, travel and accommodation
expenses, computer expenses and
stationary, where these expenses are
incurred in producing the taxpayer's
Employers are generally not liable for
fringe benefits tax for education and
training they provide or fund for their
employees in order to support employers
investing in their workers' skills.
This treatment has been maintained,
except where an employee salary
sacrifices to obtain these benefits.
PSS welcomes Meridian
The Pharmacists' Support Service (PSS)
has announced that Meridian Lawyers has
become honorary solicitor for PSS.
Meridian Lawyers is a boutique law
firm that focuses on insurance, health,
commercial and employment law
coupled with a specialist commercial
litigation and dispute resolution practice.
In particular they are widely recognised
as the leading pharmacy law practice
in Australia acting for hundreds of
pharmacists throughout the country.
They are a principal legal advisor to the
Pharmacy Guild of Australia, a number of
their state branches as well as a number
of the pharmacy educator institutes.
PSS, like all organisations, requires legal
advice from time to time. The nature of
the work of PSS, in providing support
to pharmacists, means that PSS seeks
expert advice from legal advisors who are
familiar with all aspects of pharmacy.
The President of PSS, John Coppock,
welcomed Meridian Lawyers' support
and said: 'Their experience with
pharmacy and their familiarity with the
pharmacy profession are valuable to PSS
as we provide support to pharmacists.
The advice provided by Meridian will
benefit the pharmacy profession through
our work in assisting pharmacists'.
Paul Baker, Managing Principal of
Meridian, said: 'I am delighted that we
have been appointed Honorary Solicitors
for the PSS and to be able to offer the
assistance of Meridian Lawyers generally.
PSS is such a worthy and worthwhile
cause. It is an honour to be involved'.
Meridian has joined a range of
organisations from the broader pharmacy
community who support PSS through
services and funding. PSS is entirely
funded through the generosity of the
pharmacy profession, including both
pharmacy organisations and individual
pharmacists. Donations to PSS are
Anyone wishing to support the work of
PSS by making a donation should direct
their donation to PSS c/o 381 Royal Pde,
Donations can also be made over the
phone using a credit card through
the PSA (Victorian Branch) office on
(03) 9389 4000 or by direct deposit into
the PSS bank account BSB 083170 and
account number 145988064 (please send
your name and contact details to admin@
supportforpharmacists.org.au so that a
receipt can be issued).
Pharmacists requiring assistance can
contact PSS for anonymous and discreet
support on 1300 244 910 between 8am
and 11pm EST every day of the year.
India sets price caps
India is set to introduce price controls
for an expanded list of medicines,
a move that is expected to cut into
pharmaceutical companies profits for
hundreds of medicines. The new prices
will start on 1July for 652 medicines,
348 of which are classified essential
drugs. The new pricing -- which will
be the average price of any drug with
a market share of 1% -- is expected to
lead to price cuts of up to 80% for some
cancer drugs and HIV drugs according to
PharmaTimes. The new policy replaces
an almost 20-year-old price ceiling on
74 bulk drugs and their formulations.
Hospitalisations for people with
osteoarthritis are rising, according to
information on osteoarthritis released
by the Australian Institute of Health and
Welfare (AIHW). Osteoarthritis is the most
common form of arthritis in Australia
with about 1.8 million Australians (8%
of the population) having osteoarthritis
compared to 443,000 having rheumatoid
arthritis. The new web-based report,
available at: www.aihw.gov.au, provides
a snapshot of statistics on osteoarthritis
in Australia. It shows the hospitalisation
rate for Australians with osteoarthritis
rose by 25% over the 10 years to 2010--11,
from 326 hospitalisations per 100,000
people to 408 per 100,000. Over the same
period the joint replacement surgery rate
rose by 41%.
UK atorvastatin savings
The British National Health Service
(NHS) saved more than $544 million
in the 12 months following Lipitor's
patent expiry last year according to
the British Generic Manufacturers
Association (BGMA), Pharma Times has
reported. The NHS was spending more
than $621 million annually on Lipitor
at its peak. The NHS is now spending
around $1.5 million less per day on
atorvastatin. This has been achieved by
the price dropping by more than 85%
for new generics which have come onto
Links Archive Australian Pharmacist May 2013 Australian Pharmacist July 2013 Navigation Previous Page Next Page